|Chemical and physical data|
|Molar mass||320.43 g/mol g·mol−1|
|3D model (JSmol)|
SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 of 19 nM for human CB2 receptors, and 134 nM for human CB1 receptors. It was discovered during research into the related compound SDB-001 which had been sold illicitly as "2NE1". SDB-006 metabolism has been described in literature.
|This cannabinoid related article is a stub. You can help Wikipedia by expanding it.|